SALIVARY TUMORS AND CALCULI Prof Yasser Hamza Professor

  • Slides: 79
Download presentation
SALIVARY TUMORS AND CALCULI Prof. Yasser Hamza Professor of Surgery Faculty of Medicine, University

SALIVARY TUMORS AND CALCULI Prof. Yasser Hamza Professor of Surgery Faculty of Medicine, University of Alexandria

Anatomical Considerations • Two submandibular • Two Parotid • Two sublingual • > 400

Anatomical Considerations • Two submandibular • Two Parotid • Two sublingual • > 400 minor salivary glands

Ducts

Ducts

Minor salivary glands • just under mucosa. lips, cheeks, palate, floor of mouth retro-molar

Minor salivary glands • just under mucosa. lips, cheeks, palate, floor of mouth retro-molar area. • upper aerodigestive tract • 10% of total salivary volume.

Clinical History • History of swellings / change over time • Trismus • Pain

Clinical History • History of swellings / change over time • Trismus • Pain • Variation with meals • Bilateral • Dry mouth. dry eyes • Recent exposure to mumps • Radiation history • Current medications

Diagnostic approach Clinical examination • Extra-Oral examination: • Palpate cervical lymph nodes • Palpate

Diagnostic approach Clinical examination • Extra-Oral examination: • Palpate cervical lymph nodes • Palpate the gland • Check motor function of facial nerve

Diagnostic approach Clinical examination. • Intra-Oral examination: • Gland orifice • Teeth problems •

Diagnostic approach Clinical examination. • Intra-Oral examination: • Gland orifice • Teeth problems • Oral hyegene • Lemon test • Bi-digital palpaption

Diagnostic approach Imging 1. ? ? Plain-film radiography 2. ? ? Sialography 3. Ultrasonography

Diagnostic approach Imging 1. ? ? Plain-film radiography 2. ? ? Sialography 3. Ultrasonography 4. CT 5. MRI

SIALENDOSCOPY • Allows complete exploration of the ductal system, direct visualization of duct pathology

SIALENDOSCOPY • Allows complete exploration of the ductal system, direct visualization of duct pathology • Success rate of >95% • Technically challenging • Complications: trauma could result in stenosis, perforation

Obstructive Salivary Gland Disorders • Sialolithiasis • Mucous retention/extravasation

Obstructive Salivary Gland Disorders • Sialolithiasis • Mucous retention/extravasation

Sialolithiasis ( salivary stones= calculi) “One or more round or oval calcified structures in

Sialolithiasis ( salivary stones= calculi) “One or more round or oval calcified structures in the duct of the major or minor salivary glands”

Salivary calculi • Submandibular Most common • Pain subsides before swelling. • Recurrent painful

Salivary calculi • Submandibular Most common • Pain subsides before swelling. • Recurrent painful swelling at mealtime • Acute & subacute infection • Persistent obstruction leads to permanent damages to the gland.

Obstructive SG Disorders: Sialolithiasis • results in a mechanical obstuction of the salivary duct

Obstructive SG Disorders: Sialolithiasis • results in a mechanical obstuction of the salivary duct • Is the major cause of unilateral diffuse parotid or submandibular gland swelling

Sialolithiasis • exact pathogenesis unknown. • organic nidus that progressively grows by deposition of

Sialolithiasis • exact pathogenesis unknown. • organic nidus that progressively grows by deposition of layers of inorganic and organic substances.

Etiology • Water hardness • Hypercalcemia • Xerostomia • Tobacco smoking • Gout.

Etiology • Water hardness • Hypercalcemia • Xerostomia • Tobacco smoking • Gout.

Sialolithiasis Acute ductal obstruction may occur at meal time when saliva producing is at

Sialolithiasis Acute ductal obstruction may occur at meal time when saliva producing is at its maximum, the resultant swelling is sudden and can be painful.

Stone Composition • Organic; often predominate in the center • Glycoproteins • Mucopolysaccarides •

Stone Composition • Organic; often predominate in the center • Glycoproteins • Mucopolysaccarides • Bacteria! • Cellular debris • Inorganic; often in the periphery • Calcium carbonates & calcium phosphates in the form of hydroxyapatite

Reasons sialolithiasis may occur more often in the submandibular gland • Saliva more alkaline

Reasons sialolithiasis may occur more often in the submandibular gland • Saliva more alkaline • Higher concentration of calcium and phosphate in the saliva • Higher mucus content • Longer duct • Anti-gravity flow

Obstructive Salivary Gland Disorders • Sialolithiasis • Mucous retention/extravasation

Obstructive Salivary Gland Disorders • Sialolithiasis • Mucous retention/extravasation

Mucocele Extravasation is the leakage of fluid from the ducts or acini into the

Mucocele Extravasation is the leakage of fluid from the ducts or acini into the surrounding tissue. Retention: narrowed ductal opening that cannot adequately accommodate the exit of saliva produced, leading to ductal dilation and surface swelling. Less common phenomenon

Ranula • Is a term used for mucoceles that occur in the floor of

Ranula • Is a term used for mucoceles that occur in the floor of the mouth. • The name is derived form the word rana, because the swelling may resemble the translucent underbelly of the frog.

Ranula • Although the source is usually the sublingual gland, • may also arise

Ranula • Although the source is usually the sublingual gland, • may also arise from the submandibular duct • or possibly the minor salivary glands in the floor of the mouth.

Ranula • blue dome shaped swelling in the floor of mouth • larger than

Ranula • blue dome shaped swelling in the floor of mouth • larger than mucoceles & can fill the FOM & elevate tongue. • lateral to the midline.

Plunging or Cervical Ranula • Occurs when spilled mucin dissects through the mylohyoid muscle

Plunging or Cervical Ranula • Occurs when spilled mucin dissects through the mylohyoid muscle and produces swelling in the neck. • Concomitant FOM swelling may or may not be visible.

Ranula Treatment • Marsupialization has fallen into disfavor due to the excessive recurrence rate

Ranula Treatment • Marsupialization has fallen into disfavor due to the excessive recurrence rate of 60 -90% • Sublingual gland removal via intraoral approach

Salivary Gland Tumors Frequency (%) Malignant (%) Parotid glands 65 25 Submandibular gl. 10

Salivary Gland Tumors Frequency (%) Malignant (%) Parotid glands 65 25 Submandibular gl. 10 40 Sublingual gl. < 1 90 Minor Salivary gl. 25 50

Benign tumors of the parotid Pleomorphic adenoma (benign mixed tumor). 2. Warthin’s tumor (papillary

Benign tumors of the parotid Pleomorphic adenoma (benign mixed tumor). 2. Warthin’s tumor (papillary cyst adenoma lypmhomatosum). 3. Monomorphic adenoma a. Basal cell adenoma b. Canalicular adenomas c. Oncocytoma d. Myoepitheliomas 4. Granular cell tumor 5. ? ? Hemangioma 1.

Malignant neoplasm of the parotid gland 1. Mucoepidermoid carcinoma 40% 2. Adenoid cystic carcinoma

Malignant neoplasm of the parotid gland 1. Mucoepidermoid carcinoma 40% 2. Adenoid cystic carcinoma 10% 3. Acinic cell carcinoma 10 – 15 % 4. Malignant mixed tumor 7% 5. Polymorphous low grade adenocarcinoma 10% 6. Adeno carcinoma 10% 7. Squamous cell carcinoma 4%

Malignant neoplasm of the parotid gland 1. Mucoepidermoid carcinoma – 40% Can be: high,

Malignant neoplasm of the parotid gland 1. Mucoepidermoid carcinoma – 40% Can be: high, intermediate, and low-grade based on the clinical behavior and the tumor differentiation which is related to the percentage of mucinous to epidermoid cell.

Malignant neoplasm of the parotid gland 2. Adenoid cystic carcinoma – 10% unique indolent

Malignant neoplasm of the parotid gland 2. Adenoid cystic carcinoma – 10% unique indolent preneural spread skip lesions. The disease thus specific survival continuous to declined for more than 20 years after initial treatment.

3. Acinic cell carcinoma – 10 – 15 % a low-grade tumor. 4. Malignant

3. Acinic cell carcinoma – 10 – 15 % a low-grade tumor. 4. Malignant mixed tumor - 7% a high-grade malignancy. 5. Polymorphous low grade adenocarcinoma – 10% a low-grade variant of adenocarcinoma. 6. Adeno carcinoma – 10% high-grade with poor prognosis. 7. Squamous cell carcinoma – 4% It is high-grade more common in elderly patients can confused with high-grade mucoepidermoid carcinoma.

The malignant parotid tumor can be classified into: 1. High-grade: aggressive behavior, local invasion,

The malignant parotid tumor can be classified into: 1. High-grade: aggressive behavior, local invasion, and lymph node metastasis. - high grade mucoepidermoid carcinoma - adenoid cystic carcinoma - carcinoma ex phelomorphic adenoma - adenocarcinoma - aquamous cell carcinoma - undifferentiated carcinoma

The malignant parotid tumor can be classified into: 2. Intermediate grade - intermediate grade

The malignant parotid tumor can be classified into: 2. Intermediate grade - intermediate grade mucoepidermoid carcinoma - intermediate grade adenocarcinoma - oncocytic carcinoma

The malignant parotid tumor can be classified into: 3. Low-grade malignancy - low grade

The malignant parotid tumor can be classified into: 3. Low-grade malignancy - low grade mucoepidermoid carcinoma - pholymorphous low grade adenocarcinoma - acinic cell carcinoma - low grade adenocarcinoma - basal cell carcinoma

Normal Histology

Normal Histology

Pleomorphic Adenoma

Pleomorphic Adenoma

Pleomorphic Adenoma • pleomorphic adenoma contains both epithelial (E) and stromal (S) components.

Pleomorphic Adenoma • pleomorphic adenoma contains both epithelial (E) and stromal (S) components.

Warthin's Tumor • Warthin's tumor (benign papillary cystadenoma lymphomatosum) • Bilateral in 10% of

Warthin's Tumor • Warthin's tumor (benign papillary cystadenoma lymphomatosum) • Bilateral in 10% of the cases • may contain mucoid brown fluid in FNA

Warthin’s Tumor • Mid Power • Thought to arise from salivary gland inclusions within

Warthin’s Tumor • Mid Power • Thought to arise from salivary gland inclusions within lymph nodes.

Warthin’s Tumor • Epithelial Component • Consists of papillary fronds which demonstrate 2 layers

Warthin’s Tumor • Epithelial Component • Consists of papillary fronds which demonstrate 2 layers of oncocytic epitheilal cells • Cytoplasm stains deep pink and shows granularity b/c of an abundance of mitochondria • Occasionally undergoes squamous metaplasia (may mistakenly diagnose SCCa on FNA)

Warthin’s Tumor • Lymphoid Component • An abundance of this is present • Occasional

Warthin’s Tumor • Lymphoid Component • An abundance of this is present • Occasional germinal centres will be seen • Lymphoid tissue forms the core or papillary structures • Both lymphoid and oncocytic epithelial elements must be present to diagnose Warthin’s

Warthin’s Tumor • High Power • Lymphocytc infilterates. • Bilayer of epithilium.

Warthin’s Tumor • High Power • Lymphocytc infilterates. • Bilayer of epithilium.

Mucoepidermoid Carcinoma

Mucoepidermoid Carcinoma

Adenoid Cystic Carcinoma • Adenoid cystic carcinoma with Swiss cheese pattern. • It is

Adenoid Cystic Carcinoma • Adenoid cystic carcinoma with Swiss cheese pattern. • It is the second-most common malignant tumor of the salivary glands. • ACC is the most common malignant tumor found in the submandibular, sublingual, and minor salivary glands.

Acinic Cell Carcinoma • mainly in the parotid gland, also known as blue dot

Acinic Cell Carcinoma • mainly in the parotid gland, also known as blue dot tumor. • Classic multicystic pattern. • Stained by PAS. • Cells heavily stained.

Treatment • Surgery – Total conservative – Total – Extended – +/- RND

Treatment • Surgery – Total conservative – Total – Extended – +/- RND

Parotidectomy

Parotidectomy

Parotidectomy

Parotidectomy

Parotidectomy

Parotidectomy

Parotidectomy

Parotidectomy

Treatment • Postoperative Radiation – Indications • Close surgical margins (deep lobe parotid tumors,

Treatment • Postoperative Radiation – Indications • Close surgical margins (deep lobe parotid tumors, facial nerve sparing) • Microscopically positive margin • High grade including adenoid cystic • Involvement of skin, bone, nerve (gross or extensive perineural • • invasion), tumor extension beyond capsule with periglandular and soft tissue invasion LN spread Large tumors requiring radical resection Tumor spillage Recurrence

Postoperative Radiation versus Surgery for Salivary Gland Tumors: Results from the literature Series #

Postoperative Radiation versus Surgery for Salivary Gland Tumors: Results from the literature Series # PTs FUP Prognastic length factors (y) LC 5 y Surv 5 y S S/R MSKCC 92 79 17 40 44 JH 87 MDACC 155 PMH 271 S 10. 5 Stage I/II S/R 5. 8 Stage III/IV Positive nodes High-Grade 91 51 69 63 96 9. 5 19 28 82 51 49 57 75 All patients 58 92 59 7. 5 All patients 58 86 50 -56 66 -72 10 All patients - 29 68 (RFS)

Treatment • Radiation – Surgically unresectable tumors • EBRT with photon and or electrons

Treatment • Radiation – Surgically unresectable tumors • EBRT with photon and or electrons with conventional or altered fractionation • Brachytherapy ± EBRT • Neutron therapy

Treatment • Dosage – Primary treatment • Accelerated fractionation with a delayed concomitant boost

Treatment • Dosage – Primary treatment • Accelerated fractionation with a delayed concomitant boost • Phase I 1. 8 Gy daily to 36 Gy • Phase II 1. 8 Gy as in phase I in AM x 10 fractions to 54 Gy and > 6 hrs 1. 6 Gy to GTVx 10 fractions to 16 Gy • Spinal cord dose < 45 Gy. • IMRT to 70 Gy for GTV 63 Gy CTV 1 and 56 Gy CTV 2

Treatment • Dosage – Post op treatment • Administered within 6 weeks of surgery

Treatment • Dosage – Post op treatment • Administered within 6 weeks of surgery • High Risk 2. 0 Gy/fx to 60 Gy and 1. 8 Gy/fx to 63 Gy. • Small volume known microscopic disease 66 Gy. • Elective at risk 50 Gy (2. 0 Gy/fx) 54 Gy(1. 8 Gy/fx) • Gross residual 70 Gy.

Side effects • Salivary fxn • 80% of saliva produced by major salivary glands

Side effects • Salivary fxn • 80% of saliva produced by major salivary glands • Loss of salivary fxn complete >35 Gy • Dose limit to spare salivary function is 26 Gy. • Trismus • TMJ and masseter muscle < 50 Gy. PT during and after treatment

Adenoid Cystic Carcinoma • Post op RT always recommended • Post op RT of

Adenoid Cystic Carcinoma • Post op RT always recommended • Post op RT of entire pathway of adjacent cranial nerve to base of skull always recommended • Regional LN spread is 15% and elective nodal irradiation is not standard • Surgery alone LCR 25 -40% +RT 75%-80%

LOCALIZATION OF THE FACIAL NERVE

LOCALIZATION OF THE FACIAL NERVE

1. Tragal cartilage (pointer) – always point to the facial nerve. The facial nerve

1. Tragal cartilage (pointer) – always point to the facial nerve. The facial nerve is 1 cm. inferior and 1 cm. medial to the pointer.

2. Tympanomastoid fissure – FN is 4 mm inferior to the tympano mastoid fissure

2. Tympanomastoid fissure – FN is 4 mm inferior to the tympano mastoid fissure as it exit from the stylo mastoid foramen.

3. Posterior belly of digastric muscle. The facial nerve is superior to the upper

3. Posterior belly of digastric muscle. The facial nerve is superior to the upper border of the belly of the digastric muscle.

4. Retrograde inferior approach to the facial nerve. The lower branch of the facial

4. Retrograde inferior approach to the facial nerve. The lower branch of the facial nerve invariably can be found immediately external to the posterior facial vein as it exits the lower pole of the parotid gland.

5. Retrograde anterior approach. The parotid duct is constant imposition Parotid as it goes

5. Retrograde anterior approach. The parotid duct is constant imposition Parotid as it goes duct horizontally across the border of masseter muscle. It’s always accompanied by a branch of buccal or Angle of zygomatic branch mandible within 1 cm. of the duct.

CT scan

CT scan

CT scan

CT scan

operation

operation

30/10/2020 Yasser Hamza Postoperative 68

30/10/2020 Yasser Hamza Postoperative 68

Complications of parotid surgery

Complications of parotid surgery

Submadibular sialadenectomy

Submadibular sialadenectomy

Submadibular sialadenectomy

Submadibular sialadenectomy

Submadibular sialadenectomy

Submadibular sialadenectomy

Submadibular sialadenectomy

Submadibular sialadenectomy

Submadibular sialadenectomy

Submadibular sialadenectomy

New techniques • Lithtrypsy • Sialoscopy • Min invasive • …

New techniques • Lithtrypsy • Sialoscopy • Min invasive • …

Surgical Endoscopy, May 2009

Surgical Endoscopy, May 2009